Sigma, L&T land record orders; Indus CFO exit raises governance questions

Sigma Advanced Systems locked in a $104.9 million artillery export order, more than double its entire FY26 revenue of ₹492 crore. This single win transforms near-term visibility for a mid-cap pivoting from aerospace components to defence manufacturing. The margin-accretive nature should lift profitability, but the open question is execution on a seven-year timeline and whether repeat orders follow.

Larsen & Toubro secured a ₹15,000+ crore offshore wind framework contract with TenneT, marking its entry into European offshore wind at scale. The order adds meaningful revenue visibility to a record ₹7.4 trillion order book and aligns with management's pivot toward new energy. Execution will span several years, but the win cements L&T's credentials in a high-growth global segment.

Cipla won US FDA approval for a generic version of Advair Diskus, a $908 million US market for asthma and COPD. This high-value, complex respiratory product is exactly the kind of launch needed to rebuild US revenues after Revlimid erosion. The impact depends on launch timing, pricing, and market share capture, but the approval validates its DPI strategy and New York facility.

MBL Infrastructure cleared the final legal hurdle to collect a ₹82.77 crore arbitration award from PWD, after related petitions were dismissed. For a nano-cap with just ₹390 crore market cap and quarterly net profit of ₹3.76 crore, this inflow could be company-altering. The cash would strengthen a balance sheet already showing 67% revenue growth. The key test is actual collection and deployment.

Liotech Industries landed a ₹6.46 crore order, worth 18% of its market cap and about 9% of annual revenue, with a 30-day delivery window. This is material for a micro-cap that just posted 72% revenue growth in its first audited year. It demonstrates the ability to win meaningful domestic contracts. The real question is whether these orders become repeatable and at sustainable margins.

Everest Industries booked a ₹96.15 crore exceptional gain from selling its Podanur property, a windfall for a company with a ₹732 crore market cap. The sale strengthens the balance sheet and could fund working capital or debt reduction. But core revenue continues to shrink (down 28% last year) and the company recently scrapped two large capex plans amid losses. The property gain masks a struggling operations.

Indus Towers disclosed the resignation of its CFO two months after the fact, for a company with a ₹1 trillion market cap. The delayed disclosure erodes trust in governance at a time when the company is navigating Vodafone Idea exposure and an Africa expansion. While operating metrics remain steady, the lack of timely communication adds a risk premium to the stock.

Transrail Lighting plans a ₹600 crore qualified institutions placement, its first equity raise since IPO and roughly 9% of market cap. The funds are earmarked for new high-tech verticals like drones and robotics alongside its core power EPC business. The interim dividend signals confidence, but the recent FY27 guidance cut tempers enthusiasm. The QIP is a bet on growth that has yet to materialize.

Action Construction Equipment is hosting Helios Mutual Fund for a two-day investor meet after reporting a record Q1 with 20% revenue growth. Helios is known for concentrated, long-term bets, and its presence suggests due diligence that could precede stake-building. For a mid-cap with a debt-free balance sheet and a new KATO heavy-crane JV, the meeting signals growing institutional conviction.

Epigral is betting ₹600 crore (12% of its market cap) on a 125,000-ton epoxy resin plant, a strategic pivot from its earlier stated stance of avoiding forward integration. The backward integration into epichlorohydrin gives a structural cost edge, but the reversal from 'no plan to enter epoxy' in January to board approval in July raises credibility concerns. The capex will be funded 60% by debt, increasing use.

Vardhman Special Steels committed ₹1,116 crore for a forging unit, up from an earlier ₹475 crore plan. That is 38% of its market cap and over 60% of FY26 revenue. The partnership with Japan's Aichi Steel adds technology credibility, but the scale is a surprise. Analysts will need to rework capex and earnings models; the key test is whether the investment delivers the promised ROCE of about 20%.

Dynacons landed a ₹267.58 crore contract from NPCI for a data centre upgrade, representing 18.8% of FY26 revenue. This is the fourth major public-sector mandate in recent quarters, following RBI, LIC, and Central Bank of India wins. The order book now exceeds ₹3,000 crore, providing multi-year visibility for a small-cap IT infrastructure player. The real test is execution capacity and margin protection.

Lords Chloro Alkali is seeking shareholder approval for a ₹500 crore borrowing limit, exceeding its entire market cap of ₹381 crore. For a company with debt/equity of 0.69 and a 361% profit surge last year, this signals a major shift in financial strategy. The AGM vote will determine whether this aggressive debt capacity is granted; if approved, it could fund expansion or strain the balance sheet.

Aurionpro Solutions secured a $33 million three-year US contract, its largest ever, worth about 19% of FY26 revenue. The order buoys a modest Q1 where net profit fell despite revenue growth. The US deal dramatically expands Aurionpro's footprint in a high-value market and supports management's guidance for accelerating H2 growth. Execution on this contract is now the critical catalyst for the stock.